Related Experiment Video
Updated: Jan 2, 2026
14:10
Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Published on: January 31, 2013
33.7K
Muscular dystrophies
Eugenio Mercuri1, Carsten G Bönnemann2, Francesco Muntoni3
1Pediatric Neurology Unit, Università Cattolica del Sacro Cuore Roma, Rome, Italy; Nemo Clinical Centre, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
Lancet (London, England)
|December 3, 2019
Summary
Genetic mutations cause muscular dystrophies, impacting muscle health. Advances in diagnosis and supportive care improve patient outcomes and quality of life, with new therapies emerging.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Muscular dystrophies are genetic muscle diseases caused by mutations in over 40 genes.
- These conditions lead to characteristic dystrophic changes observable on muscle biopsy.
- Identifying responsible genes enables accurate diagnosis and subtype-specific care.
Purpose of the Study:
- To review clinical manifestations, molecular pathogenesis, diagnostic strategies, and therapeutic advancements for muscular dystrophies.
- To highlight the impact of genetic discoveries and supportive medicine on patient care.
- To discuss the development of novel therapies, particularly for Duchenne muscular dystrophy.
Main Methods:
- Review of current literature on muscular dystrophies.
- Analysis of diagnostic approaches based on genetic identification.
- Examination of therapeutic strategies and clinical trial outcomes.
Main Results:
- Identification of most causative genes allows for precise diagnosis and tailored management.
- Advances in supportive care have significantly improved survival and quality of life.
- Novel therapies, including personalized treatments for Duchenne muscular dystrophy, are progressing through clinical development.
Conclusions:
- Genetic insights have transformed the diagnosis and management of muscular dystrophies.
- Improved understanding of pathogenesis fuels the development of effective treatments.
- The future holds promise for enhanced patient outcomes through targeted therapies and comprehensive care.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
01:28Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
01:26Cross-bridge Cycle
121.8K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
121.8K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
325
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
325
01:43Sex-linked Disorders
108.0K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
108.0K
01:13Formation of Muscle Fibers from Myoblasts
5.7K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.7K